Advanced search
Publication Cover
Orphan Drugs: Research and Reviews Volume 3, 2013 - Issue
Journal homepage
24
Views
0
CrossRef citations to date
0
Altmetric
Review

Tipifarnib and farnesyltransferase inhibitors in the treatment of inflammatory breast cancer: is the story over? A review

Irene Dehghan-Paz1 Division of Hematology and Oncology, Rush University Medical Center, Chicago, IL, USA
,
Dora Il’yasova2 Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA
,
Kenneth L van Golen3 Department of Biological Sciences, University of Delaware, Newark, DE, USA
&
Lydia Usha1 Division of Hematology and Oncology, Rush University Medical Center, Chicago, IL, USACorrespondence[email protected]
Pages 11-21 | Published online: 15 May 2013

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.